loading...| Preferred Name |
deslorelin |
| Synonyms |
LHRH, tryptophyl(6)-N-ethylglycinamide(10)- |
| ID |
http://purl.bioontology.org/ontology/MESH/C066438 |
| altLabel |
LHRH, tryptophyl(6)-N-ethylglycinamide(10)- D-Trp(6)-N-Et-D-GlyNH2(10)-LHRH LHRH, Trp(6)-N-Et-GlyNH2(10)- 6-Trp-10-N-Et-GlyNH2-LHRH Somagard Ovuplant deslorelin acetate GnRh, Trp(6)-N-Et-GlyNH2(10)- |
| cui |
C1529913 C0378713 C0378714 C0083220 C0112166 |
| Has mapping qualifier | |
| HM |
D017329/Q000031 |
| II |
D000426/Q000037 |
| Inverse of RB |
679007NR5C TKG3I66TVE |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19901221 |
| MeSH Frequency |
275 |
| MMR |
20141027 |
| notation |
C066438 |
| PA |
D004791 |
| PI |
Gonadorelin/*analogs & derivatives (1990-2002) |
| prefLabel |
deslorelin |
| RR |
70235-53-9 (deslorelin) 679007NR5C |
| SC |
1 |
| Scope Statement |
Ovuplant is tradename for a short-term-release implant containing deslorelin acetate; RN given refers to D-isomer; RN for cpd without isomeric designation not avail 12/90 |
| SRC |
Cell Mol Biol 1990;36(3):291 |
| TERMUI |
T212322 T212323 T212321 T212318 T212320 T212319 T212317 T212324 T623504 |
| TH |
US FDA SRS (2013) USAN (19XX) NLM (1990) AU INN (19XX) |
| tui |
T116 T121 |